Warfarin or aspirin for recurrent ischemic stroke.
Publication
, Journal Article
Algra, A; European-Australian Stroke Prevention in Reversible Ischemia Trial Study Group,
Published in: N Engl J Med
April 11, 2002
Duke Scholars
Published In
N Engl J Med
EISSN
1533-4406
Publication Date
April 11, 2002
Volume
346
Issue
15
Start / End Page
1169 / 1171
Location
United States
Related Subject Headings
- Warfarin
- Stroke
- Secondary Prevention
- Platelet Aggregation Inhibitors
- International Normalized Ratio
- Humans
- Hemorrhage
- General & Internal Medicine
- Brain Ischemia
- Aspirin
Citation
APA
Chicago
ICMJE
MLA
NLM
Algra, A., & European-Australian Stroke Prevention in Reversible Ischemia Trial Study Group, . (2002). Warfarin or aspirin for recurrent ischemic stroke. N Engl J Med, 346(15), 1169–1171.
Algra, Ale, and Ale European-Australian Stroke Prevention in Reversible Ischemia Trial Study Group. “Warfarin or aspirin for recurrent ischemic stroke.” N Engl J Med 346, no. 15 (April 11, 2002): 1169–71.
Algra A, European-Australian Stroke Prevention in Reversible Ischemia Trial Study Group. Warfarin or aspirin for recurrent ischemic stroke. N Engl J Med. 2002 Apr 11;346(15):1169–71.
Algra, Ale, and Ale European-Australian Stroke Prevention in Reversible Ischemia Trial Study Group. “Warfarin or aspirin for recurrent ischemic stroke.” N Engl J Med, vol. 346, no. 15, Apr. 2002, pp. 1169–71.
Algra A, European-Australian Stroke Prevention in Reversible Ischemia Trial Study Group. Warfarin or aspirin for recurrent ischemic stroke. N Engl J Med. 2002 Apr 11;346(15):1169–1171.
Published In
N Engl J Med
EISSN
1533-4406
Publication Date
April 11, 2002
Volume
346
Issue
15
Start / End Page
1169 / 1171
Location
United States
Related Subject Headings
- Warfarin
- Stroke
- Secondary Prevention
- Platelet Aggregation Inhibitors
- International Normalized Ratio
- Humans
- Hemorrhage
- General & Internal Medicine
- Brain Ischemia
- Aspirin